Decreased platelet size is associated with platelet activation and anti-phospholipid syndrome in systemic lupus erythematosus. 2017

Christian Lood, and Helena Tydén, and Birgitta Gullstrand, and Christoffer T Nielsen, and Niels H H Heegaard, and Petrus Linge, and Andreas Jönsen, and Roger Hesselstrand, and Robin Kahn, and Anders A Bengtsson
Department of Clinical Sciences Lund, Section of Rheumatology, Lund, Sweden.

. SLE is an autoimmune disease with increased cardiovascular morbidity and platelet activation. In the general population, increased platelet size predicts platelet reactivity and cardiovascular disease. The aim of this study was to investigate whether platelet size related to platelet activation and cardiovascular disease in SLE. . Fresh blood samples from SLE patients ( n = 148), healthy volunteers ( n = 79) and disease controls ( n = 40) were analysed for platelet size and activation by flow cytometry, ELISA and cell count. Associations to manifest cardiovascular disease, venous thrombosis and APS were adjusted for traditional cardiovascular risk factors using logistic regression analysis. . SLE patients had decreased platelet size as compared with healthy controls ( P = 0.003). In SLE, decreased platelet size was related to increased platelet activation, in particular microparticle formation ( P < 0.0001, r = -0.46) and release of serotonin from dense granules ( P < 0.001, r = 0.57). SLE patients with aCL had decreased platelet size ( P = 0.02) and aCL decreased platelet size in vitro ( P = 0.007). In contrast to the general population, increased platelet size was not associated with cardiovascular disease. Instead, decreased platelet size was associated with secondary APS, even after adjusting for traditional cardiovascular risk factors ( P = 0.01, odds ratio 3.58). . Platelet size is decreased in SLE patients and associated with microparticle formation and APS. Future studies are needed to determine the underlying mechanism(s) as well as the potential predictive value of small platelets for disease complications in SLE.

UI MeSH Term Description Entries
D008180 Lupus Erythematosus, Systemic A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys, and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow. Libman-Sacks Disease,Lupus Erythematosus Disseminatus,Systemic Lupus Erythematosus,Disease, Libman-Sacks,Libman Sacks Disease
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D001792 Blood Platelets Non-nucleated disk-shaped cells formed in the megakaryocyte and found in the blood of all mammals. They are mainly involved in blood coagulation. Platelets,Thrombocytes,Blood Platelet,Platelet,Platelet, Blood,Platelets, Blood,Thrombocyte
D002318 Cardiovascular Diseases Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM. Adverse Cardiac Event,Cardiac Events,Major Adverse Cardiac Events,Adverse Cardiac Events,Cardiac Event,Cardiac Event, Adverse,Cardiac Events, Adverse,Cardiovascular Disease,Disease, Cardiovascular,Event, Cardiac
D002452 Cell Count The number of CELLS of a specific kind, usually measured per unit volume or area of sample. Cell Density,Cell Number,Cell Counts,Cell Densities,Cell Numbers,Count, Cell,Counts, Cell,Densities, Cell,Density, Cell,Number, Cell,Numbers, Cell
D004797 Enzyme-Linked Immunosorbent Assay An immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase. While either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye. Many variations of the method have been developed. ELISA,Assay, Enzyme-Linked Immunosorbent,Assays, Enzyme-Linked Immunosorbent,Enzyme Linked Immunosorbent Assay,Enzyme-Linked Immunosorbent Assays,Immunosorbent Assay, Enzyme-Linked,Immunosorbent Assays, Enzyme-Linked
D005260 Female Females
D005434 Flow Cytometry Technique using an instrument system for making, processing, and displaying one or more measurements on individual cells obtained from a cell suspension. Cells are usually stained with one or more fluorescent dyes specific to cell components of interest, e.g., DNA, and fluorescence of each cell is measured as it rapidly transverses the excitation beam (laser or mercury arc lamp). Fluorescence provides a quantitative measure of various biochemical and biophysical properties of the cell, as well as a basis for cell sorting. Other measurable optical parameters include light absorption and light scattering, the latter being applicable to the measurement of cell size, shape, density, granularity, and stain uptake. Cytofluorometry, Flow,Cytometry, Flow,Flow Microfluorimetry,Fluorescence-Activated Cell Sorting,Microfluorometry, Flow,Cell Sorting, Fluorescence-Activated,Cell Sortings, Fluorescence-Activated,Cytofluorometries, Flow,Cytometries, Flow,Flow Cytofluorometries,Flow Cytofluorometry,Flow Cytometries,Flow Microfluorometries,Flow Microfluorometry,Fluorescence Activated Cell Sorting,Fluorescence-Activated Cell Sortings,Microfluorimetry, Flow,Microfluorometries, Flow,Sorting, Fluorescence-Activated Cell,Sortings, Fluorescence-Activated Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

Christian Lood, and Helena Tydén, and Birgitta Gullstrand, and Christoffer T Nielsen, and Niels H H Heegaard, and Petrus Linge, and Andreas Jönsen, and Roger Hesselstrand, and Robin Kahn, and Anders A Bengtsson
August 2017, Rheumatology (Oxford, England),
Christian Lood, and Helena Tydén, and Birgitta Gullstrand, and Christoffer T Nielsen, and Niels H H Heegaard, and Petrus Linge, and Andreas Jönsen, and Roger Hesselstrand, and Robin Kahn, and Anders A Bengtsson
August 2017, Rheumatology (Oxford, England),
Christian Lood, and Helena Tydén, and Birgitta Gullstrand, and Christoffer T Nielsen, and Niels H H Heegaard, and Petrus Linge, and Andreas Jönsen, and Roger Hesselstrand, and Robin Kahn, and Anders A Bengtsson
December 2003, La Revue du praticien,
Christian Lood, and Helena Tydén, and Birgitta Gullstrand, and Christoffer T Nielsen, and Niels H H Heegaard, and Petrus Linge, and Andreas Jönsen, and Roger Hesselstrand, and Robin Kahn, and Anders A Bengtsson
November 2008, La Revue du praticien,
Christian Lood, and Helena Tydén, and Birgitta Gullstrand, and Christoffer T Nielsen, and Niels H H Heegaard, and Petrus Linge, and Andreas Jönsen, and Roger Hesselstrand, and Robin Kahn, and Anders A Bengtsson
May 2001, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine,
Christian Lood, and Helena Tydén, and Birgitta Gullstrand, and Christoffer T Nielsen, and Niels H H Heegaard, and Petrus Linge, and Andreas Jönsen, and Roger Hesselstrand, and Robin Kahn, and Anders A Bengtsson
July 2018, Rheumatology (Oxford, England),
Christian Lood, and Helena Tydén, and Birgitta Gullstrand, and Christoffer T Nielsen, and Niels H H Heegaard, and Petrus Linge, and Andreas Jönsen, and Roger Hesselstrand, and Robin Kahn, and Anders A Bengtsson
January 2003, Clinical and experimental dermatology,
Christian Lood, and Helena Tydén, and Birgitta Gullstrand, and Christoffer T Nielsen, and Niels H H Heegaard, and Petrus Linge, and Andreas Jönsen, and Roger Hesselstrand, and Robin Kahn, and Anders A Bengtsson
October 2003, No to shinkei = Brain and nerve,
Christian Lood, and Helena Tydén, and Birgitta Gullstrand, and Christoffer T Nielsen, and Niels H H Heegaard, and Petrus Linge, and Andreas Jönsen, and Roger Hesselstrand, and Robin Kahn, and Anders A Bengtsson
April 2004, British journal of haematology,
Christian Lood, and Helena Tydén, and Birgitta Gullstrand, and Christoffer T Nielsen, and Niels H H Heegaard, and Petrus Linge, and Andreas Jönsen, and Roger Hesselstrand, and Robin Kahn, and Anders A Bengtsson
October 2006, Rheumatology (Oxford, England),
Copied contents to your clipboard!